Learn more

SOLVAY PHARM GMBH

Overview
  • Total Patents
    1,150
About

SOLVAY PHARM GMBH has a total of 1,150 patent applications. Its first patent ever was published in 1989. It filed its patents most often in EPO (European Patent Office), Canada and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are NEUROGASTRX INC, NERRE THERAPEUTICS LTD and MANLEY PAUL W.

Patent filings per year

Chart showing SOLVAY PHARM GMBHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Antel Jochen 221
#2 Waldeck Harald 147
#3 Ziegler Dieter 126
#4 Gregory Peter-Colin 122
#5 Preuschoff Ulf 110
#6 Eeckhout Christian 101
#7 Messinger Josef 94
#8 Jasserand Daniel 91
#9 Sann Holger 87
#10 David Samuel 82

Latest patents

Publication Filing date Title
WO2009153261A1 HYDROXYPHENYL-SUBSTITUTED PYRROLO[2,3d]PYRIMIDINE DERIVATIVES, PROCESSES AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE COMPOUNDS
TW200948399A Improved formulations for poorly permeable active pharmaceutical ingredients
BRPI0820628A2 process to separate and determine viral load in a pancreatin sample
US2009130063A1 Process for separating and determining the viral load in a pancreatin sample
US2009104126A1 Sulfamate Compounds and Uses Thereof
TW200927090A Novel sulfamate compounds for medical use
WO2008113851A2 Novel c11 modified retrosteroids as progesterone receptor modulator compounds
EP2099814A1 Substituted estratrien derivatives as 17beta hsd inhibitors
CN102796161A Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors
US2008085889A1 Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
CN101472593A Use of adenosine A1 antagonist in radiocontrast media induced nephropathy
TW200808819A Use of adenosine A1 antagonists in radiocontrast media induced nephrophaty
ZA200810834B Long term 24 hour intestinal administration of levodopa/carbidopa
US2007254862A1 Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
BRPI0711064A2 Pharmaceutical compositions comprising cbx cannabinoid receptor modulators and potassium channel modulators
CN101431994A Use of CBx cannabinoid receptor modulators as potassium channel modulators
US2007219214A1 Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation
CA2641817A1 Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparation
US2007212751A1 Microbial method for the 11beta hydroxylation of 9beta, 10alpha-steriods
AU2007206959A1 Process for the preparation of 11beta-hydr0xy-9beta, 10alpha -steroids employing amycolatopsis mediterranei cells